New York, US – September 20, 2019 – As a world-renowned service provider engaged in chimeric antigen receptor (CAR)-engineered T (CAR-T) cell therapy field for years, Creative Biolabs has helped numerous global clients obtain the most suitable services or products based on the largest collection of CAR products of different generations targeting various biomarkers. Benefiting from the proprietary Smart™ CAR Construction Service System established by a knowledgeable team, Creative Biolabs can provide highly individualized solutions to CAR-T Cell Development, TCR modified T Cell, CAR modified natural killer (CAR-NK) cell and CAR modified macrophage.
In recent years, CAR-T cell therapy has been proved a remarkably efficient approach for the treatment of a variety of tumors. On one hand, to assist with different projects from global clients, Creative Biolabs offers a list of customized CAR-T therapy services covering the whole CAR-T therapy development process, which include but are not limited to Biomarker Identification & Selection, High Affinity ScFv Generation, CAR Design & Construction, Virus Packaging & CAR Gene Delivery, CAR-T In Vitro Assay, CAR-T Preclinical In Vivo Assay, CAR-T Clinical Trial.
On the other hand, Creative Biolabs also provides a wide range of early development service for TCR modified T cell, biomarker identification and selection, design, construction, and analysis. Meanwhile, the preclinical test is also available. Besides,γδ CAR-T, another novel format of CAR-T, has been successfully operated for therapeutic to kill tumor cells and eliminate infected cells with their own T-cells more effectively.
In addition to the conventional CAR construction services, scientists at Creative Biolabs are capable of engineering the novel CAR modified NK cells for immunological researches and clinical trials by taking the advantage its superior ability with a much faster immune reaction. More detailly, scientist engineer CAR-NK cells from ceaseless NK cells and constructed mutant NK92 cells to reduce limitations of wild-type iPSC-NK cells. Ph.D. level scientists and skillful technicians can guarantee clients with continuously produced and widely used NK cells.
With the endless enthusiasm at the scientific field and the principle to address each specific need of customers, experts from Creative Biolabs have overcome the limitations in solid tumor that lies in the poor penetration of T cells into tumors by turning to genetically engineered CAR modified macrophage, also termed MOTO-CAR, enhancing the ability of CAR cells to attack solid tumors.
More information on any CAR-T related products or service all can be reached at https://www.creative-biolabs.com/car-t
About Creative Biolabs
As a global company, Creative Biolabs has more than 200 talented and well-trained scientists located in different continents working closely with partners from the entire world to develop and produce medicines of tomorrow. Specifically, the established leading experts in TCR and CAR T&NK cell immune therapy development offer the one-stop custom services that cover the entire new drug development pipeline, and an exclusive line of ready-to-use TCR and CAR T&NK cell construction products, such as virus packaging, purification, expansion and titer determination kits. Furthermore, a unique unparalleled CAR construction and production platform has been built up for all four CAR generations.
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Address:45-1 Ramsey Road
State: New York
Country: United States